Effectiveness and cost comparison of two strategies for hepatitis B vaccination of schoolchildren

Canadian Journal of Public Health

Volumn 94, Issue 1, 2003, Pages 64-67

  Guay, Maryse ^a,b,c   Clouâtre, Anne Marie ^a   Blackburn, Manon ^a,b   Baron, Geneviève ^a,c   De Wals, Philippe ^a,b,c   Roy, Chantale ^d   Desrochers, Jean ^d   Milord, François ^a,b  

^a Regie Reg Serv Social/S M   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ARTICLE; CANADA; CHILD HEALTH CARE; COMMUNITY CARE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE PLANNING; HEPATITIS B; HUMAN; IMMUNIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; QUESTIONNAIRE; SCHOOL CHILD; SCHOOL HEALTH SERVICE; STATISTICAL ANALYSIS;

EID: 0037258176     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405055     Document Type: Article

References (23)

1. Ministère de la Santé et des Services sociaux, Circulaire 1994-04-05 sur le programme de vaccination contre l'hépatite B. Québec: Direction de la protection de la santé publique, Ministère de la Santé et des Services sociaux, 1994.
2. Plaitano S, Sagliocca L, Mele A, Bove C, Protano D, Adamo B, et al. Hepatitis B mass immunization of adolescents: A pilot study in a community. Eur J Epidemiol 1993;9(3):307-10.
3. Centers for Disease Control and Prevention. Hepatitis B vaccination of adolescents - California, Louisiana and Oregon, 1992-1994. MMWR 1994;43:605-9.
4. Poulin C, Duval B, Alary M, Ringuet J, Pelletier G, Bouchard A. Étude de faisabilité de l'application d'un programme de vaccination contre l'hépatite B chez les adolescents en milieu scolaire. Québec: Ministère de la Santé et des Services sociaux, 1994.
5. Cassidy WM, Mahoney FJ. A hepatitis B vaccination program targeting adolescents. J Adolesc Health 1995;17(4):244-47.
6. Dobson S, Scheifele D, Bell A. Assessment of a universal, school-based hepatitis B vaccination program. JAMA 1995;274(15):1209-13.
7. Stewart P, MacDonald N, Manion I. School-based hepatitis B immunization program: Follow-up of non-participants at first school clinic. Can J Public Health 1997;88(3):192-96.
8. Bloom BS, Hillman AL, Fendrick AM, Schwartz JS. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann Intern Med 1993;118(4):298-306.
9. Krahn M, Detsky AS. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost effectiveness analysis. Med Decision Making 1993;13(1):4-20.
10. Krahn M, Guasparini R, Sherman M, Decsky AS. Cost and cost-effectiveness of a universal, school-based hepatitis B vaccination program. Am J Public Health 1998;88(11):1638-44.
11. Kerleau M, Flori YA, Nalpas JL, Lanoe JL, Berthelot P, Fardeau-Gauthier M. Analyse coût-avantage d'une politique de prévention, vaccinale de l'hépatite virale B. Rev Épidémiol Santé Publ 1995;43(1):48-60.
12. Mangtani P, Hall AJ, Normand CE. Hepatitis B vaccination: The cost effectiveness of alternative strategies in England and Wales. J Epidemiol Community Health 1995;49(3):238-44.
13. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA 1995;274(15):1201-8.
14. Garuz R, Torrea JL, Amal JM, Forcens T, Trinxet C, Anton F, et al. Vaccination against hepatitis B virus in Spain: A cost-effectiveness analysis. Vaccine 1997;15:1652-60.
15. Deuson RR, Hoekstra EJ, Sedjo R, Bakker G, Melinkovich P, Daeke D, et al. The Denver School-Based Adolescent Hepatitis B Vaccination Program: A Cost Analysis With Risk Simulation. Am J Public Health 1999;89(11):1722-27.
16. Wilson T. Economic evaluation of a metropolitan-wide, school-based hepatitis B vaccination program. Public Health Nurs 2000;17(3):222-27.
17. Gyorkos TW, Tannenbaum TN, Abrahamowicz M, Bédard L, Carsley J, Franco ED, et al. Evaluation of the effectiveness of immunization delivery methods. Can J Public Health 1994;85(S1):14-30.
18. Task Force on Community Preventive Services. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med 2000;18(1S):92-96.
19. Centers for Disease Control and Prevention. Vaccine-preventable diseases: Improving vaccination coverage in children, adolescents, and adults. A report on recommendations of the Task Force on Community Preventive Services. MMWR 1999;48(RR-8):1-15.
20. Shefer A, Briss P, Rodewald L, Bernier R, Strikas R, Yusuf H, et al. Improving immunization coverage rates: An evidence-based review of the literature. Epidemiol Rev 1999;21(1):96-142.
21. Junod B, Wietlisbach V. Méthodes et stratégies d'évaluation du programme national suisse de recherche sur la prévention des maladies cardiovasculaires. Rev Épidémiol Santé Publ 1981;29:315-25.
22. Duval B, Boulianne N, De Serres G, Laflamme N, DeWals P, Masse R, et al. Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10 year-old children. Vaccine 2000;18(15):1467-72.
23. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes, Second Edition. Oxford: Oxford University Press, 1997.